On September 2, 2025, our patent is granted.<\/p>\n
Mesenchymal stromal cells (Mesenchymal Stem Cells; MSCs)* are anticipated to exert various therapeutic effects, including anti-inflammatory properties, and have been the subject of extensive research. However, the detailed molecular mechanisms and modes of action remain largely unclear.<\/p>\n
Our company has elucidated that the conditioned medium containing secretions from MSCs regulates the expression of genes deeply associated with skin elasticity, firmness, and barrier function. Based on this discovery, we have obtained a patent.<\/p>\n
This finding demonstrates, from the perspective of gene expression, that MSCs may be involved in skin wound healing, atopic dermatitis, and hair growth\/regeneration. We consider this patent to be a highly significant foundational achievement.<\/p>\n